| 000 | 01865 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515055515.0 | ||
| 264 | 0 | _c20070801 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.00481-06 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPellegrin, Isabelle | |
| 245 | 0 | 0 |
_aInterpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cApr 2007 |
||
| 300 |
_a1473-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOrganophosphates _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aRitonavir _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aBreilh, Dominique | |
| 700 | 1 | _aCoureau, Gaelle | |
| 700 | 1 | _aBoucher, Sébastien | |
| 700 | 1 | _aNeau, Didier | |
| 700 | 1 | _aMerel, Patrick | |
| 700 | 1 | _aLacoste, Denis | |
| 700 | 1 | _aFleury, Hervé | |
| 700 | 1 | _aSaux, Marie-Claude | |
| 700 | 1 | _aPellegrin, Jean-Luc | |
| 700 | 1 | _aLazaro, Estibaliz | |
| 700 | 1 | _aDabis, François | |
| 700 | 1 | _aThiébaut, Rodolphe | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 51 _gno. 4 _gp. 1473-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00481-06 _zAvailable from publisher's website |
| 999 |
_c16856360 _d16856360 |
||